Novo Nordisk sweetens bid for Metsera with an offer of up to $10 billion
Nov 4 (Reuters) - Novo Nordisk NOVOb.CO is now offering up to $10 billion for Metsera MTSR.O, up from its prior offer of up to $8.5 billion, the obesity drug developer said on Tuesday. (Reporting by Christy Santhosh and Siddhi Mahatole in Bengaluru; Editing by Maju Samuel) ((Christy.Santhosh@thomsonreuters.com;))
Recent news on Metsera
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up